You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 3, March 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Public Health, Other
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Neoplasms
 •Dermatologic Disorders, Other
 •Public Health
 •Alert me on articles by topic

COMMENTS AND OPINIONS
Assessment of Delayed Reporting of Mycosis Fungoides and Sézary Syndrome in the United States

Graça M. Dores, MD, MPH; Rochelle E. Curtis, MA; William F. Anderson, MD, MPH; Marie-France Demierre, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Using data from the Surveillance, Epidemiology and End Results Program (SEER), Criscione and Weinstock1 described increasing incidence rates (IRs) for cutaneous T-cell lymphoma (CTCL) in the United States. The authors speculate that IRs may be underestimated owing to possible underregistration and delayed reporting. Underregistration or underreporting is difficult to assess; however, delayed reporting can be evaluated in SEER.2-3 Delayed reporting refers to cases submitted by SEER to the National Cancer Institute (NCI) after an allowable ascertainment period. Before submitting data to NCI, SEER registries have a 2-year period to collect information on all newly diagnosed cancer cases. Cases collected after this 2-year ascertainment period are reported on subsequent data submissions, thereby resulting in revised estimates of IRs for the earlier time period.2

Herein, we assess delayed reporting of mycosis fungoides and Sézary syndrome . . . [Full Text of this Article]


AUTHOR INFORMATION






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.